Next Article in Journal
Flexible Substrate-Compatible and Efficiency-Improved Quantum-Dot Light-Emitting Diodes with Reduced Annealing Temperature of NiOx Hole-Injecting Layer
Previous Article in Journal
Sepiolite-Supported Manganese Oxide as an Efficient Catalyst for Formaldehyde Oxidation: Performance and Mechanism
Previous Article in Special Issue
Bioactive Compounds from Organic Waste
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical and Bioactive Evaluation of Essential Oils from Edible and Aromatic Mediterranean Lamiaceae Plants

by
Rafael M. Spréa
1,2,3,
Cristina Caleja
1,2,
Tiane C. Finimundy
1,2,
Ricardo C. Calhelha
1,2,
Tânia C. S. P. Pires
1,2,
Joana S. Amaral
1,2,
Miguel A. Prieto
3,*,
Isabel C. F. R. Ferreira
1,2,
Eliana Pereira
1,2,* and
Lillian Barros
1,2
1
Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
2
Laboratório Associado para a Sustentabilidade e Tecnologia em Regiões de Montanha (SusTEC), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
3
Department of Analytical Chemistry and Food Science, Instituto de Agroecoloxía e Alimentación (IAA)—CITEXVI, Universidade de Vigo, 36310 Vigo, Spain
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(12), 2827; https://doi.org/10.3390/molecules29122827
Submission received: 1 May 2024 / Revised: 3 June 2024 / Accepted: 10 June 2024 / Published: 13 June 2024

Abstract

:
The Lamiaceae family, which includes several well-known aromatic plants, is scientifically relevant due to its essential oils (EOs). In this work, four EOs from Mediterranean species, namely Origanum vulgare L., Rosmarinus officinalis L., Salvia officinalis L., and Thymus vulgaris L., were evaluated for their volatile profiles and the biological activity in vitro to assess their potential use in the food and cosmetic sector. GC/MS analysis revealed dominant compounds, such as carvacrol, thymol, and eucalyptol. Regarding biological action, the samples exhibited antioxidant, cytotoxic, anti-inflammatory, antimicrobial, and antifungal activities, with O. vulgare and T. officinalis standing out. T. vulgaris showed the lowest EC50 in the reducing power assay, and O. vulgare had the lowest EC50 in the DPPH assay. Most EOs also displayed excellent anti-inflammatory responses and antifungal properties, with O. vulgare and T. vulgaris also demonstrating antibacterial activity. All EOs from Mediterranean species showed cytotoxicity against tumoral cell lines. Overall, the selected EOs stood out for their interesting bioactivities, with the obtained results underscoring their potential as natural preservatives and bioactive agents in various industrial applications, including food, pharmaceuticals, and cosmetics.

Graphical Abstract

1. Introduction

The Lamiaceae family comprises 236 genera and approximately 7200 plant species [1]. Throughout history, these plants have gained recognition for their culinary value as seasoning and flavoring agents, as well as for their traditional medicinal uses [2]. Scientific studies have reported the presence of compounds with significant relevance in different plant organs and essential oils within this family that are associated with their aromatic and bioactive properties [3]. Moreover, several members of the Lamiaceae family, such as mint, sage, oregano, thyme, basil, and rosemary, have been integral components of the Mediterranean diet, highlighting their extensive use in the culinary traditions of this region [4].
Essential oils (EOs) are complex mixtures mainly composed of several terpenes, commonly used as natural ingredients [5]. Essential oils of common spices, such as clove, cinnamon, basil, nutmeg, thyme, and oregano, are considered in the category Generally Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Furthermore, the GRAS status of EOs has engendered considerable interest in their use in the food preservation industry [6]. Contemporary trends in the food industry underscore a growing consumer preference toward environmentally sustainable options and a reduced reliance on synthetic chemical preservatives. In this context, EOs emerge as a promising alternative for replacing or decreasing the use of chemical additives, such as synthetic antioxidants and preservatives, and improving food packaging [7,8,9].
Some studies have highlighted the flavoring, antioxidant, and anti-inflammatory properties of different essential oils [10,11]. However, the application of EOs as food preservatives requires good knowledge of their properties, such as microbial and antioxidant sensitivity and the effects when in contact with the food matrix [12]. In addition to the food industry, EOs can also be used in sectors, such as cosmetics, to develop new fragrances and products for hair and skin care [13,14], and agriculture, as bioagents to prevent the development of pests during crop growth [15].
In this study, a preliminary selection of plants of this family cultivated in Portugal with potential for industrial-scale use was performed based on three main criteria, namely their status as aromatic plants commonly used in culinary practices, potential suitability for the extraction of EOs in accordance with the scientific literature, and origin as either native to the Mediterranean ecosystem or cultivated within this region. Consequently, four species of edible and aromatic plants, Origanum vulgare L. (oregano), Rosmarinus officinalis L. (rosemary), Salvia officinalis L. (sage), and Thymus vulgaris L. (thyme), were specifically chosen as focal subjects for essential-oil extraction by Clevenger hydrodistillation. Several studies have addressed certain parameters related to the composition and bioactivity of essential oils of said species; however, few articles have simultaneously evaluated the chemical composition and various biological activities of the same work. This article aims to fill this gap by providing a comprehensive and integrated analysis of the composition and antioxidant, cytotoxic, anti-inflammatory, and antimicrobial activities of essential oils extracted from Lamiaceae plants. Overall, the work seeks to contribute valuable insights for the future exploitation of aromatic plants at an industrial scale, potentially benefiting sectors such as food, pharmaceuticals, and cosmetics.

2. Results and Discussion

2.1. Composition in Volatile Compounds

GC/MS analysis allowed the identification of 90.3–92.3% of the compounds, considering all the EOs analyzed. In total, 9 compounds were identified in O. vulgare EO, 13 in S. officinalis EO, and 16 compounds in the EOs of R. officinalis and T. vulgaris (Table 1). All the essential oils showed a predominance of oxygenated monoterpenes, followed by monoterpene hydrocarbons. Nevertheless, S. officinalis and O. vulgaris presented a much higher content of oxygenated monoterpenes (81 and 86%, respectively) as compared to R. officinalis and T. vulgaris (53 and 48%, respectively), which in turn showed a higher number of monoterpenes (around 40%, while S. officinalis and O. vulgaris had <10%). In addition, O. vulgaris showed the presence of oxygenated sesquiterpenes, though in minor amounts (0.64 and 1.613%), while sesquiterpenes were also evidenced in S. officinalis EO (1.156%). However, T. vulgaris EO was the only sample that simultaneously presented these two groups, although sesquiterpenes were present as minority compounds (0.1%).
Carvacrol, a monoterpene recognized as having antioxidant, antimicrobial, and anti-inflammatory effects, as previously reviewed [16], was the main oxygenated monoterpene present in O. vulgare EO (85.78%), in agreement with previous studies reported in the literature. Caputo et al. comprehensively examined different drying methods of O. vulgare and reported carvacrol as the predominant compound in the EO obtained by the different drying techniques tested [17]. Elshafie et al. also reported carvacrol as the main constituent of O. vulgare EO [18]. Several beneficial effects have been associated with this compound, namely increased shelf-life of food products, mainly due to its powerful antioxidant and antimicrobial properties [19], as well as antimutagenic activity [18] and antimicrobial [20,21] and anticancer properties [22]. Carvacrol was also observed in the EO of T. vulgaris, although in smaller amounts (5.1%). In this species, the major terpene observed was thymol (41%), which is consistent with previous studies conducted by Ed-Dra et al., who investigated the use of T. vulgaris EO as a natural additive [23]. In this study, the authors also concluded that thymol is related to the inhibitory effect of T. vulgaris EO on different serotypes of Salmonella enterica, as also suggested by other works [24,25]. Thymol, an isomer of carvacrol, is directly associated with Thymus vulgaris as it is frequently found in this species [26]. This monoterpene has been significantly studied over the years, with various biological activities being attributed to it, notably antioxidant, anti-inflammatory, and antimicrobial properties [27,28,29]. Its applications, the identification of its mechanisms of action, and its pharmacokinetic studies position thymol as a potential agent for medicinal treatments [30].
Regarding R. officinalis EO, eucalyptol was the main terpene observed (34%). Eucalyptol is commonly found in Eucalyptus essential oil, but it can also be found in other plants. The literature reports this compound as an excellent antimicrobial; however, studies are still scarce [31]. Similar amounts of eucalyptol were also described by Amina et al. (37.97%), who suggested that the antioxidant activity exhibited by this oil can be related to the high content of this compound [32]. Moreover, the literature reports eucalyptol as a terpene that exhibits moderate inhibitory action against different microorganisms [33].
However, the EO of S. officinalis proved to be rich in camphor (29%), a terpene with antioxidant properties that can be used in food and pharmaceutical industries [34]. The extensive use of camphor in industries is due to the fact that this monoterpene is associated with the induction of apoptotic cell death through oxidative stress in a unicellular eukaryotic model [35]. Previous studies also found camphor as the major compound in the EO of this species, with its content ranging from 25.1 to 33.6% [36,37]. Khedher et al. concluded that the antioxidant and antimicrobial activities of the EO may be attributed to the composition of terpenes, suggesting that the presence of camphor contributes to its bioactive properties [37].
The significant presence of the aforementioned terpenes is consistently associated with biological activity. Characterizing and quantifying these compounds provide a better understanding of the EOs and their potential in future applications, including as natural additives in food products, antimicrobial agents, and antioxidants.

2.2. Antioxidant Activity

The results of the two in vitro assays (RP and DPPH) performed to evaluate the antioxidant activity are presented in Table 2. Overall, O. vulgare and T. vulgaris stood out for their better antioxidant properties as compared to the other samples, demonstrating the lowest values of DPPH and RP, respectively. T. vulgaris presented the lowest EC50 value in the reducing power assay (1.63 mg/mL), closely followed by O. vulgare (1.69 mg/mL), while O. vulgare performed better in the DPPH assay (9.23 mg/mL) than T. vulgaris (10.68 mg/mL). Laothaweerungsawat et al. reported that the EO of commercial O. vulgare from Mediterranean regions (Spain) exhibits a lower EC50 than the oil extracted from highland areas in tropical regions (Thailand); however, the results obtained in this work are in line with those reported in the literature [38]. Similar to O. vulgare EO, T. vulgaris EO also exhibited lower values of EC50, demonstrating good antioxidant activity, as previously reported by Mancini et al. when investigating the chemical composition and antioxidant potential of T. vulgaris collected in three different areas of Italy [39].
R. officinalis EO presented the highest value of EC50, particularly for DPPH (55.86 mg/mL), demonstrating its lower antioxidant capacity. While similar EC50 values were reported by el Kharraf et al. for the reducing power assay of the R. officinalis EO obtained by steam distillation [40], in previous studies conducted on the EO extracted through distillation from R. officinalis grown in Morocco [41], a lower EC50 value was obtained for the DPPH assay as compared to this study.
Regarding S. officinalis EO, the EC50 obtained in the DPPH assay is in agreement with previous results that reported similar values for the antioxidant activity (EC50 = 8.31 ± 0.55 mg/mL) [36]. However, better results were obtained for the reducing power assay as compared to those (EC50 = 28.5 ± 0.3) previously reported [37]. The variations in the antioxidant potential and the discrepancies in reported values for the same botanical species can be attributed to various factors, such as geographical region, cultivation conditions, and plant maturity [42]. The superior antioxidant response exhibited by the essential oils (EOs) from Origanum vulgare and T. vulgaris may be attributed to the presence of terpenes belonging to the phenol class, particularly carvacrol and thymol. Previous studies have demonstrated that terpenes belonging to the class of phenols exhibit higher antioxidant activity, followed by terpene aldehydes and ketones [43]. However, eucalyptol (ether) and camphor (ketone) were the predominant terpenes in R. officinalis and S. officinalis, with lower antioxidant activity being reported for their essential oils.

2.3. Cytotoxicity Potential

Cytotoxicity results of the EOs obtained from the different plants are presented in Table 3. Four tumoral cell lines, namely AGS (human gastric epithelial cell line), CaCo2 (human colorectal adenocarcinoma cell line), MCF7 (human breast carcinoma cell line), and NCI-H460 (human lung carcinoma cell line), were inhibited by all EOs with GI50 < 306 μg/mL, demonstrating their cytotoxic potential. The lowest GI50, denotating better activity, was observed for O. vulgare EO against all tumoral cell lines, ranging from 45 to 84 μg/mL. The cytotoxicity activity of O. vulgare EO rich in carvacrol was also reported against human skin cells [44]. On the contrary, the NCI-H460 cell line was the most resistant against the EOs tested as it showed the highest GI50 values. R. officinalis EO presented GI50 values from 60 to 306 μg/mL, which is in agreement with previous reports [45]. Likewise, T. vulgaris EO exhibited GI50 values close to those reported against three cellular lines, namely MCF7, HepG-2 (hepatic carcinoma), and HeLa [39] cell lines.
In addition, S. officinalis and T. vulgaris showed cytotoxic effects against the non-tumoral VERO cell line at a GI50 concentration of 243 μg/mL. Therefore, additional in vivo studies are necessary to verify the toxicity of these oils for specific applications.

2.4. Anti-Inflammatory Activity

All the EOs extracted from the four evaluated Lamiaceae species demonstrated excellent anti-inflammatory results (Table 4) based on the assay using the macrophage cell line RAW264., since all except R. officinalis presented better activity as compared to the positive control dexamethasone. Among the samples, T. vulgaris had the lowest GI50 (8 μg/mL), agreeing with the results previously reported [28,46], which also reported the capacity of T. vulgaris EO to inhibit NO production. S. officinalis and O. vulgare EOs also evidenced lower GI50 results as compared to the positive control. The EO obtained from R. officinalis oil showed a GI50 of 58.1 μg/mL, also in line with the literature [47]. The suppression of the inflammatory response of these EOs has also been reported in the literature [38,48,49].

2.5. Antimicrobial Activity

Table 5 reports the antibacterial and antifungal activity of the EOs against foodborne pathogens. None of the EOs showed bactericidal activity at the maximum concentration tested (2.5% v/v) against P. aeruginosa, B. cereus, and L. monocytogenes. Overall, O. vulgare EO demonstrated the highest antibacterial potency, followed by T. vulgaris. The former notably exhibited bacteriostatic activity against all tested strains, also evidencing the lowest MIC values across all bacteria. Additionally, it displayed bactericidal activity at low concentrations (0.08–0.63%) against four strains (E. coli, S. enterica, Y. enterocolitica, and S. aureus). T. vulgare EO was ineffective against P. aeruginosa but was able to successfully inhibit all other assayed bacteria. Compared to O. vulgare EO, T. vulgare EO exhibited a lower efficacy, as it generally presented higher MIC and MBC values for the same tested bacteria, except for E. coli, where it showed a lower MBC value.
Contrary to these two samples, S. officinalis and R. officinalis EOs showed low antibacterial activity, since for most bacteria, they only exhibited bacteriostatic activity at the highest concentration tested (2.5%, v/v) and bactericidal activity was only evidenced by R. officinalis EO against E. coli.
Previously reported results were consistent with those of this study, indicating that the EO of O. vulgaris could be a natural source of antimicrobial compounds. Using a different method, the agar disk diffusion method, Simirgiotis et al. reported a high sensitivity of bacteria against O. vulgare EO from Chile [50]. The EO was diluted in ethanol to an initial concentration of 10% v/v and tested against foodborne bacteria (E. coli, P. aeruginosa, S. enterica, B. cereus, and S. aureus), exhibiting MIC values between 0.08 and 0.63% (v/v) and MBC values from 0.08 to 1.25% (v/v). Kosakowska et al. also reported a significant inhibitory effect using the agar disk diffusion method for O. vulgare EO from Poland [51]. Regarding T. vulgaris EO, prior studies have also demonstrated its inhibitory and bacteriostatic effect using the agar disk diffusion method [24,52], aligning with the findings of this study.
Numerous studies have reported the fungicidal activity of EOs derived from Lamiaceae plants against a range of fungal pathogens, associating the activity to the volatile composition that can disrupt fungal cell membranes, inhibit fungal growth, and interfere with essential cellular processes [1,53,54,55]. In this work, all the tested EOs had good inhibitory and fungicidal potential as they showed values close to (A. brasiliensis) or even lower than (A. fumigatus) those of the positive control (ketaconazole). The EO of O. vulgare stood out for its low MIC value (0.08%, v/v) against A. brasiliensis. All tested EOs presented fungicidal values of 0.31%, with the exception of R. officinalis (0.63%). Notably, A. fumigatus showed greater sensitivity to all tested EOs, with MIC = 0.08% and MBC = 0.31%.

3. Materials and Methods

3.1. Sample Preparation

Origanum vulgare L., Rosmarinus officinalis L., Salvia officinalis L., and Thymus vulgaris L. were kindly provided in dried form by the certified industry Deifil (Póvoa de Lanhoso, Portugal). Aerial parts of the four Lamiaceae plants were transported to the laboratory facilities and stored in a dry place, protected from light and moisture. Before analysis, they were ground to a powder (model A327R1, Moulinex, Barcelona, Spain) to approximately 20 mesh and stored at room temperature.

3.2. Volatile Compounds

The aerial parts of the aromatic edible plants were submitted for essential-oil extraction by hydrodistillation. For this purpose, the plant parts were kept in the Clevenger apparatus for 3 h with distilled water in a ratio of 1:20 (m/v). The EO was recovered without the addition of any solvent, and anhydrous sodium sulfate was added to eliminate any traces of water from the samples. Subsequently, the EO was diluted in n-hexane (1:100) and analyzed by GC/MS using a Perkin Elmer system with a Clarus® 580 GC module, Perkin Elmer, Waltham, MA, USA and a Clarus® SQ 8 S MS module, equipped with a DB-5MS fused-silica column (30 m × 0.25 mm i.d., film thickness 0.25 μm; J & W Scientific, Inc., Folsom, CA, USA), under the conditions previously described by [56].

3.3. Bioactivity Evaluation

3.3.1. Antioxidant Activity

Antioxidant properties were evaluated by two in vitro assays, reducing power (RP) and 2,2-diphenyl-1-picrylhydrazyl (DPPH), as previously described [56]. Results were expressed in EC50 for the DPPH assay, which translates the concentration of the EO that scavenges 50% of the radicals, and in EC50 for RP, corresponding to 0.5 of absorbance at 690 nm. For both methodologies, a SpectroStar nano-spectrophotometer reader (Labtech, Ortenberg, Germany) was used. Butylated hydroxytoluene (BHT), calcium ascorbate (E302), and sodium metabisulphite (E223), as organic molecules commonly used as food additives, were used as positive controls.

3.3.2. Cytotoxicity Activity

A sulforhodamine B colorimetric assay was performed to evaluate the cytotoxicity potential of the samples against four human tumor cell lines, namely AGS (human gastric epithelial cell line), CaCo2 (human colorectal adenocarcinoma cell line), MCF7 (human breast carcinoma cell line), and NCI-H460 (human lung carcinoma cell line), following the methodology previously described by [56]. Furthermore, cytotoxicity against non-tumoral cells was assessed in VERO (African green monkey kidney) cells. All cell lines used in the in vitro assays were obtained from Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH. Ellipticine was used as the positive control. Results were expressed as the concentration of essential oil with the ability to inhibit 50% of cell growth (GI50).

3.3.3. Anti-Inflammatory Activity

The murine macrophage cell line (RAW 264.7, European Collection of Authenticated Cell Cultures) was used to evaluate the anti-inflammatory potential, as described by [56]. Furthermore, a commercial corticosteroid (dexamethasone) was used as a positive control. The results were presented as the concentration of extract causing 50% inhibition of nitric oxide (NO) production (IC50, µg/mL).

3.3.4. Antimicrobial Activity

The antibacterial activity was evaluated using three Gram-positive bacteria, namely Bacillus cereus (ATCC 11778), Listeria monocytogenes (ATCC 19111), and Staphylococcus aureus (ATCC 25923), and four Gram-negative strains, namely Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 9027), Salmonella enterica (ATCC 13076), and Yersinia enterocolitica (ATCC 8610), following the protocol described by [57]. Two micromycetes, Aspergillus fumigatus (ATCC 204305) and Aspergillus brasiliensis (ATCC 16404), were used to determine the inhibitory and fungicidal activity of the essential oils, as described by [56]. Results were expressed as the minimum inhibitory concentration (MIC) and the minimum bactericidal or fungicidal concentration (MBC/MFC), as % (v/v) of essential oil.

3.4. Statistical Analyses

Results of assays performed in triplicate were presented as the mean ± standard deviation. The statistical software used for data analysis in this study was SPSS Statistics (IBM SPSS Statistics for Windows, version 23.0). To assess the statistical differences among multiple groups, analysis of variance (ANOVA) was performed, followed by a post hoc Tukey test. The threshold for statistical significance was set at p < 0.05. In cases where the sample size was less than three, Student’s t-test was used to evaluate significant differences between two samples, with a significance level of p = 0.05.

4. Conclusions

This study provides valuable scientific knowledge about the composition and bioactivity of EOs extracted from four Lamiaceae plants. The EOs from the selected plants exhibit a distinct composition, although all are dominated by oxygenated monoterpenes, with carvacrol being the main compound in O. vulgare EO, thymol in T. vulgaris EO, eucalyptol in R. officinalis EO, and camphor in S. officinalis EO. The presence of these bioactive compounds aligns with the previous literature and supports the diverse and significant biological activities of the four EOs, including antioxidant, cytotoxic, anti-inflammatory, and antimicrobial properties. Overall, O. vulgare and T. vulgaris EO demonstrate particularly noteworthy antioxidant and antimicrobial properties, with O. vulgare EO also exhibiting remarkable cytotoxic activity against various tumoral cell lines. These findings support their potential use in various applications, including in food preservation, as antioxidant ingredients, in applications in smart packaging and antimicrobial packaging, in the cosmetic and pharmaceutical fields as natural preservatives, and in aromatherapy applications. In the future, essential oils can be subjected to the HET-CAM assay to assess the biocompatibility of the compounds, thereby expanding future prospects for the safe and effective use of these products in various applications.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/molecules29122827/s1: Chromatograms obtained by GC/MS of essential oils. Extraction methodology and extraction parameters are described in Section 3.2.

Author Contributions

Conceptualization, R.M.S., J.S.A., E.P., I.C.F.R.F. and M.A.P.; formal analysis, R.M.S., T.C.S.P.P., T.C.F. and R.C.C.; investigation, R.M.S., E.P., T.C.F., T.C.S.P.P. and R.C.C.; methodology, R.M.S., C.C., T.C.S.P.P. and R.C.C.; supervision, J.S.A. and L.B.; writing—original draft, R.M.S., C.C., E.P. and J.S.A.; writing—review and editing, C.C., E.P., M.A.P., J.S.A., I.C.F.R.F. and L.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by national funding by FCT/MCTES (PIDDAC): CIMO, UIDB/00690/2020 (DOI: 10.54499/UIDB/00690/2020) and UIDP/00690/2020 (DOI: 10.54499/UIDP/00690/2020); national funding by SusTEC, LA/P/0007/2020 (DOI: 10.54499/LA/P/0007/2020); national funding by FCT, P.I., through the institutional and individual scientific employment program-contracts for L. Barros, R. Calhelha, and E. Pereira (2021.03908.CEECIND); and research contracts of C. Caleja, T. Finimundy, and T.C.S.P. Pires (VIIAFOOD project no. C644929456-00000040) and Rafael Mascoloti Spréa (2020.08092.BD).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material; further inquiries can be directed to the corresponding author/s.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Karpiński, T.M. Essential Oils of Lamiaceae Family Plants as Antifungals. Biomolecules 2020, 10, 103. [Google Scholar] [CrossRef]
  2. Kozłowska, M.; Laudy, A.E.; Przybył, J.; Ziarno, M.; Majewska, E. Chemical composition and antibacterial activity of some medicinal plants from lamiaceae family. Acta Pol. Pharm. 2015, 72, 757–767. [Google Scholar] [PubMed]
  3. Ramos da Silva, L.R.; Ferreira, O.O.; Cruz, J.N.; de Jesus Pereira Franco, C.; Oliveira dos Anjos, T.; Cascaes, M.M.; Almeida da Costa, W.; Helena de Aguiar Andrade, E.; Santana de Oliveira, M. Lamiaceae Essential Oils, Phytochemical Profile, Antioxidant, and Biological Activities. Evid.-Based Complement. Altern. Med. 2021, 2021, 1–18. [Google Scholar] [CrossRef] [PubMed]
  4. Stefanaki, A.; van Andel, T. Mediterranean Aromatic Herbs and Their Culinary Use. In Aromatic Herbs in Food; Elsevier: Amsterdam, The Netherlands, 2021; pp. 93–121. [Google Scholar]
  5. Xavier, V.; Spréa, R.; Finimundy, T.C.; Heleno, S.A.; Amaral, J.S.; Barros, L.; Ferreira, I.C.F.R. Terpenes. In Natural Secondary Metabolites: From Nature, through Science, to Industry; Carocho, M., Heleno, S.A., Barros, L., Eds.; Springer International Publishing: Cham, Switzerland, 2023; pp. 107–156. ISBN 978-3-031-18587-8. [Google Scholar]
  6. Jackson-Davis, A.; White, S.; Kassama, L.S.; Coleman, S.; Shaw, A.; Mendonca, A.; Cooper, B.; Thomas-Popo, E.; Gordon, K.; London, L. A Review of Regulatory Standards and Advances in Essential Oils as Antimicrobials in Foods. J. Food Prot. 2023, 86, 100025. [Google Scholar] [CrossRef] [PubMed]
  7. Ju, J.; Chen, X.; Xie, Y.; Yu, H.; Guo, Y.; Cheng, Y.; Qian, H.; Yao, W. Application of Essential Oil as a Sustained Release Preparation in Food Packaging. Trends Food Sci. Technol. 2019, 92, 22–32. [Google Scholar] [CrossRef]
  8. Sharma, S.; Cheng, S.-F.; Bhattacharya, B.; Chakkaravarthi, S. Efficacy of Free and Encapsulated Natural Antioxidants in Oxidative Stability of Edible Oil: Special Emphasis on Nanoemulsion-Based Encapsulation. Trends Food Sci. Technol. 2019, 91, 305–318. [Google Scholar] [CrossRef]
  9. Sharma, S.; Mulrey, L.; Byrne, M.; Jaiswal, A.K.; Jaiswal, S. Encapsulation of Essential Oils in Nanocarriers for Active Food Packaging. Foods 2022, 11, 2337. [Google Scholar] [CrossRef] [PubMed]
  10. Garzoli, S.; Petralito, S.; Ovidi, E.; Turchetti, G.; Laghezza Masci, V.; Tiezzi, A.; Trilli, J.; Cesa, S.; Casadei, M.A.; Giacomello, P.; et al. Lavandula x Intermedia Essential Oil and Hydrolate: Evaluation of Chemical Composition and Antibacterial Activity before and after Formulation in Nanoemulsion. Ind. Crops Prod. 2020, 145, 112068. [Google Scholar] [CrossRef]
  11. Seow, Y.X.; Yeo, C.R.; Chung, H.L.; Yuk, H.-G. Plant Essential Oils as Active Antimicrobial Agents. Crit. Rev. Food Sci. Nutr. 2014, 54, 625–644. [Google Scholar] [CrossRef]
  12. Hyldgaard, M.; Mygind, T.; Meyer, R.L. Essential Oils in Food Preservation: Mode of Action, Synergies, and Interactions with Food Matrix Components. Front. Microbiol. 2012, 3, 12. [Google Scholar] [CrossRef]
  13. Diass, K.; Brahmi, F.; Mokhtari, O.; Abdellaoui, S.; Hammouti, B. Biological and Pharmaceutical Properties of Essential Oils of Rosmarinus officinalis L. and Lavandula officinalis L. Mater. Today Proc. 2021, 45, 7768–7773. [Google Scholar] [CrossRef]
  14. Guzmán, E.; Lucia, A. Essential Oils and Their Individual Components in Cosmetic Products. Cosmetics 2021, 8, 114. [Google Scholar] [CrossRef]
  15. Ebadollahi, A.; Ziaee, M.; Palla, F. Essential Oils Extracted from Different Species of the Lamiaceae Plant Family as Prospective Bioagents against Several Detrimental Pests. Molecules 2020, 25, 1556. [Google Scholar] [CrossRef] [PubMed]
  16. Mączka, W.; Twardawska, M.; Grabarczyk, M.; Wińska, K. Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties. Antibiotics 2023, 12, 824. [Google Scholar] [CrossRef]
  17. Caputo, L.; Amato, G.; de Bartolomeis, P.; De Martino, L.; Manna, F.; Nazzaro, F.; De Feo, V.; Barba, A.A. Impact of Drying Methods on the Yield and Chemistry of Origanum vulgare L. Essential Oil. Sci. Rep. 2022, 12, 3845. [Google Scholar] [CrossRef] [PubMed]
  18. Elshafie, H.; Armentano, M.; Carmosino, M.; Bufo, S.; De Feo, V.; Camele, I. Cytotoxic Activity of Origanum vulgare L. on Hepatocellular Carcinoma Cell Line HepG2 and Evaluation of Its Biological Activity. Molecules 2017, 22, 1435. [Google Scholar] [CrossRef] [PubMed]
  19. Rathod, N.B.; Kulawik, P.; Ozogul, F.; Regenstein, J.M.; Ozogul, Y. Biological Activity of Plant-Based Carvacrol and Thymol and Their Impact on Human Health and Food Quality. Trends Food Sci. Technol. 2021, 116, 733–748. [Google Scholar] [CrossRef]
  20. Mauriello, E.; Ferrari, G.; Donsì, F. Effect of Formulation on Properties, Stability, Carvacrol Release and Antimicrobial Activity of Carvacrol Emulsions. Colloids Surf. B Biointerfaces 2021, 197, 111424. [Google Scholar] [CrossRef]
  21. Rúa, J.; del Valle, P.; de Arriaga, D.; Fernández-Álvarez, L.; García-Armesto, M.R. Combination of Carvacrol and Thymol: Antimicrobial Activity Against Staphylococcus Aureus and Antioxidant Activity. Foodborne Pathog. Dis. 2019, 16, 622–629. [Google Scholar] [CrossRef]
  22. Günes-Bayir, A.; Kiziltan, H.S.; Kocyigit, A.; Güler, E.M.; Karataş, E.; Toprak, A. Effects of Natural Phenolic Compound Carvacrol on the Human Gastric Adenocarcinoma (AGS) Cells in Vitro. Anti-Cancer Drugs 2017, 28, 522–530. [Google Scholar] [CrossRef]
  23. Ed-Dra, A.; Nalbone, L.; Filali, F.R.; Trabelsi, N.; El Majdoub, Y.O.; Bouchrif, B.; Giarratana, F.; Giuffrida, A. Comprehensive Evaluation on the Use of Thymus vulgaris Essential Oil as Natural Additive against Different Serotypes of Salmonella Enterica. Sustainability 2021, 13, 4594. [Google Scholar] [CrossRef]
  24. Galovičová, L.; Borotová, P.; Valková, V.; Vukovic, N.L.; Vukic, M.; Štefániková, J.; Ďúranová, H.; Kowalczewski, P.Ł.; Čmiková, N.; Kačániová, M. Thymus vulgaris Essential Oil and Its Biological Activity. Plants 2021, 10, 1959. [Google Scholar] [CrossRef] [PubMed]
  25. Marchese, A.; Orhan, I.E.; Daglia, M.; Barbieri, R.; Di Lorenzo, A.; Nabavi, S.F.; Gortzi, O.; Izadi, M.; Nabavi, S.M. Antibacterial and Antifungal Activities of Thymol: A Brief Review of the Literature. Food Chem. 2016, 210, 402–414. [Google Scholar] [CrossRef]
  26. Escobar, A.; Pérez, M.; Romanelli, G.; Blustein, G. Thymol Bioactivity: A Review Focusing on Practical Applications. Arab. J. Chem. 2020, 13, 9243–9269. [Google Scholar] [CrossRef]
  27. Nikolić, M.; Glamočlija, J.; Ferreira, I.C.F.R.; Calhelha, R.C.; Fernandes, Â.; Marković, T.; Marković, D.; Giweli, A.; Soković, M. Chemical Composition, Antimicrobial, Antioxidant and Antitumor Activity of Thymus serpyllum L., Thymus Algeriensis Boiss. and Reut and Thymus vulgaris L. Essential Oils. Ind. Crops Prod. 2014, 52, 183–190. [Google Scholar] [CrossRef]
  28. de Oliveira, J.R.; de Jesus Viegas, D.; Martins, A.P.R.; Carvalho, C.A.T.; Soares, C.P.; Camargo, S.E.A.; Jorge, A.O.C.; de Oliveira, L.D. Thymus vulgaris L. Extract Has Antimicrobial and Anti-Inflammatory Effects in the Absence of Cytotoxicity and Genotoxicity. Arch. Oral Biol. 2017, 82, 271–279. [Google Scholar] [CrossRef] [PubMed]
  29. Costa, M.F.; Durço, A.O.; Rabelo, T.K.; Barreto, R.d.S.; Guimarães, A.G. Effects of Carvacrol, Thymol and Essential Oils Containing Such Monoterpenes on Wound Healing: A Systematic Review. J. Pharm. Pharmacol. 2019, 71, 141–155. [Google Scholar] [CrossRef]
  30. Milovanovic, S.; Markovic, D.; Mrakovic, A.; Kuska, R.; Zizovic, I.; Frerich, S.; Ivanovic, J. Supercritical CO2—Assisted Production of PLA and PLGA Foams for Controlled Thymol Release. Mater. Sci. Eng. C 2019, 99, 394–404. [Google Scholar] [CrossRef]
  31. Spisni, E.; Petrocelli, G.; Imbesi, V.; Spigarelli, R.; Azzinnari, D.; Donati Sarti, M.; Campieri, M.; Valerii, M.C. Antioxidant, Anti-Inflammatory, and Microbial-Modulating Activities of Essential Oils: Implications in Colonic Pathophysiology. Int. J. Mol. Sci. 2020, 21, 4152. [Google Scholar] [CrossRef]
  32. Amina, B.; Soumeya, B.; Salim, B.; Mahieddine, B.; Sakina, B.; Chawki, B.; Francesca, N.; Marzia, V.; Carmine, N.; Luigi, D.B. Chemical Profiling, Antioxidant, Enzyme Inhibitory and in Silico Modeling of Rosmarinus officinalis L. and Artemisia Herba Alba Asso. Essential Oils from Algeria. S. Afr. J. Bot. 2022, 147, 501–510. [Google Scholar] [CrossRef]
  33. Yang, P.; Jia, M.; Zhu, L. Acaricidal Activity of the Essential Oil from Senecio Cannabifolius and Its Constituents Eucalyptol and Camphor on Engorged Females and Larvae of Rhipicephalus Microplus (Acari: Ixodidae). Exp. Appl. Acarol. 2021, 83, 411–426. [Google Scholar] [CrossRef]
  34. Kim, T.; Song, B.; Cho, K.S.; Lee, I.-S. Therapeutic Potential of Volatile Terpenes and Terpenoids from Forests for Inflammatory Diseases. Int. J. Mol. Sci. 2020, 21, 2187. [Google Scholar] [CrossRef] [PubMed]
  35. Ağuş, H.; Yilmaz, S.; Şengoz, C. Crosstalk between Autophagy and Apoptosis Induced by Camphor inSchizosaccharomyces Pombe. Turk. J. Biol. 2019, 43, 382–390. [Google Scholar] [CrossRef]
  36. El Euch, S.K.; Hassine, D.B.; Cazaux, S.; Bouzouita, N.; Bouajila, J. Salvia Officinalis Essential Oil: Chemical Analysis and Evaluation of Anti-Enzymatic and Antioxidant Bioactivities. S. Afr. J. Bot. 2019, 120, 253–260. [Google Scholar] [CrossRef]
  37. Khedher, M.R.B.; Khedher, S.B.; Chaieb, I.; Tounsi, S.; Hammami, M. Chemical Composition and Biological Activities of Salvia Officinalis Essential Oil from Tunisia. EXCLI J. 2017, 16, 160–173. [Google Scholar] [PubMed]
  38. Laothaweerungsawat, N.; Sirithunyalug, J.; Chaiyana, W. Chemical Compositions and Anti-Skin-Ageing Activities of Origanum vulgare L. Essential Oil from Tropical and Mediterranean Region. Molecules 2020, 25, 1101. [Google Scholar] [CrossRef] [PubMed]
  39. Mancini, E.; Senatore, F.; Del Monte, D.; De Martino, L.; Grulova, D.; Scognamiglio, M.; Snoussi, M.; De Feo, V. Studies on Chemical Composition, Antimicrobial and Antioxidant Activities of Five Thymus vulgaris L. Essential Oils. Molecules 2015, 20, 12016–12028. [Google Scholar] [CrossRef] [PubMed]
  40. El Kharraf, S.; El-Guendouz, S.; Farah, A.; Bennani, B.; Mateus, M.C.; El Hadrami, E.M.; Miguel, M.G. Hydrodistillation and Simultaneous Hydrodistillation-Steam Distillation of Rosmarinus officinalis and Origanum Compactum: Antioxidant, Anti-Inflammatory, and Antibacterial Effect of the Essential Oils. Ind. Crops Prod. 2021, 168, 113591. [Google Scholar] [CrossRef]
  41. Oualdi, I.; Diass, K.; Azizi, S.; Dalli, M.; Touzani, R.; Gseyra, N.; Yousfi, E.B. Rosmarinus officinalis Essential Oils from Morocco: New Advances on Extraction, GC/MS Analysis, and Antioxidant Activity. Nat. Prod. Res. 2022, 37, 2003–2008. [Google Scholar] [CrossRef]
  42. Hlwatika, C.N.M.; Bhat, R.B. An Ecological Interpretation of the Difference in Leaf Anatomy and Its Plasticity in Contrasting Tree Species in Orange Kloof, Table Mountain, South Africa. Ann. Bot. 2002, 89, 109–114. [Google Scholar] [CrossRef]
  43. Gonzalez-Burgos, E.; Gomez-Serranillos, M.P. Terpene Compounds in Nature: A Review of Their Potential Antioxidant Activity. CMC 2012, 19, 5319–5341. [Google Scholar] [CrossRef]
  44. Han, X.; Parker, T.L. Anti-Inflammatory, Tissue Remodeling, Immunomodulatory, and Anticancer Activities of Oregano (Origanum vulgare) Essential Oil in a Human Skin Disease Model. Biochim. Open 2017, 4, 73–77. [Google Scholar] [CrossRef] [PubMed]
  45. Dolghi, A.; Coricovac, D.; Dinu, S.; Pinzaru, I.; Dehelean, C.A.; Grosu, C.; Chioran, D.; Merghes, P.E.; Sarau, C.A. Chemical and Antimicrobial Characterization of Mentha Piperita L. and Rosmarinus officinalis L. Essential Oils and In Vitro Potential Cytotoxic Effect in Human Colorectal Carcinoma Cells. Molecules 2022, 27, 6106. [Google Scholar] [CrossRef]
  46. Abdelli, W.; Bahri, F.; Romane, A.; Höferl, M.; Wanner, J.; Schmidt, E.; Jirovetz, L. Chemical Composition and Anti-Inflammatory Activity of Algerian Thymus vulgaris Essential Oil. Nat. Prod. Commun. 2017, 12, 1934578X1701200. [Google Scholar] [CrossRef]
  47. Carbone, C.; Martins-Gomes, C.; Caddeo, C.; Silva, A.M.; Musumeci, T.; Pignatello, R.; Puglisi, G.; Souto, E.B. Mediterranean Essential Oils as Precious Matrix Components and Active Ingredients of Lipid Nanoparticles. Int. J. Pharm. 2018, 548, 217–226. [Google Scholar] [CrossRef] [PubMed]
  48. Mohammed, H.A.; Eldeeb, H.M.; Khan, R.A.; Al-Omar, M.S.; Mohammed, S.A.A.; Sajid, M.S.M.; Aly, M.S.A.; Ahmad, A.M.; Abdellatif, A.A.H.; Eid, S.Y.; et al. Sage, Salvia Officinalis L., Constituents, Hepatoprotective Activity, and Cytotoxicity Evaluations of the Essential Oils Obtained from Fresh and Differently Timed Dried Herbs: A Comparative Analysis. Molecules 2021, 26, 5757. [Google Scholar] [CrossRef]
  49. Tosun, A.; Khan, S.; Kim, Y.; Calín-Sánchez, A.; Hysenaj, X.; Carbonell-Barrachina, A. Essential Oil Composition and Anti-Inflammatory Activity of Salvia officinalis L (Lamiaceae) in Murin Macrophages. Trop. J. Pharm. Res. 2014, 13, 937. [Google Scholar] [CrossRef]
  50. Simirgiotis, M.J.; Burton, D.; Parra, F.; López, J.; Muñoz, P.; Escobar, H.; Parra, C. Antioxidant and Antibacterial Capacities of Origanum vulgare L. Essential Oil from the Arid Andean Region of Chile and Its Chemical Characterization by GC-MS. Metabolites 2020, 10, 414. [Google Scholar] [CrossRef]
  51. Kosakowska, O.; Węglarz, Z.; Pióro-Jabrucka, E.; Przybył, J.L.; Kraśniewska, K.; Gniewosz, M.; Bączek, K. Antioxidant and Antibacterial Activity of Essential Oils and Hydroethanolic Extracts of Greek Oregano (O. vulgare L. Subsp. Hirtum (Link) Ietswaart) and Common Oregano (O. vulgare L. Subsp. Vulgare). Molecules 2021, 26, 988. [Google Scholar] [CrossRef]
  52. Borugă, O.; Jianu, C.; Mişcă, C.; Goleţ, I.; Gruia, A.; Horhat, F. Thymus vulgaris Essential Oil: Chemical Composition and Antimicrobial Activity. J. Med. Life 2014, 7, 56–60. [Google Scholar]
  53. De Martino, L.; De Feo, V.; Nazzaro, F. Chemical Composition and in Vitro Antimicrobial and Mutagenic Activities of Seven Lamiaceae Essential Oils. Molecules 2009, 14, 4213–4230. [Google Scholar] [CrossRef] [PubMed]
  54. Nieto, G. Biological Activities of Three Essential Oils of the Lamiaceae Family. Medicines 2017, 4, 63. [Google Scholar] [CrossRef] [PubMed]
  55. Waller, S.B.; Cleff, M.B.; Serra, E.F.; Silva, A.L.; Gomes, A.d.R.; de Mello, J.R.B.; de Faria, R.O.; Meireles, M.C.A. Plants from Lamiaceae Family as Source of Antifungal Molecules in Humane and Veterinary Medicine. Microb. Pathog. 2017, 104, 232–237. [Google Scholar] [CrossRef] [PubMed]
  56. Sprea, R.M.; Fernandes, L.H.M.; Pires, T.C.S.P.; Calhelha, R.C.; Rodrigues, P.J.; Amaral, J.S. Volatile Compounds and Biological Activity of the Essential Oil of Aloysia Citrodora Paláu: Comparison of Hydrodistillation and Microwave-Assisted Hydrodistillation. Molecules 2023, 28, 4528. [Google Scholar] [CrossRef] [PubMed]
  57. Xavier, V.; Finimundy, T.C.; Heleno, S.A.; Amaral, J.S.; Calhelha, R.C.; Vaz, J.; Pires, T.C.S.P.; Mediavilla, I.; Esteban, L.S.; Ferreira, I.C.F.R.; et al. Chemical and Bioactive Characterization of the Essential Oils Obtained from Three Mediterranean Plants. Molecules 2021, 26, 7472. [Google Scholar] [CrossRef]
Table 1. Chemical volatile profiles of the four Lamiaceae essential oils extracted by hydrodistillation by the Clevenger apparatus.
Table 1. Chemical volatile profiles of the four Lamiaceae essential oils extracted by hydrodistillation by the Clevenger apparatus.
Origanum vulgare L.
NumberCompoundRT (min)LRI aLRI bRelative % c
1α-Pinene8.4589269320.076 ± 0.001
2Camphene9.1239409460.048 ± 0.003
3β-Pinene10.1389859740.012 ± 0.001
4o-Cymene12.798101810220.53 ± 0.02
5γ-Terpinene14.461105210540.82 ± 0.03
6Terpinolene16.876110210884.4 ± 0.2
7Thymol25.61128712890.013 ± 0.0001
8Carvacrol26.9751318129885.78 ± 0.02
9Caryophyllene oxide37.336156815820.64 ± 0.04
Total identified (%) 92.3 ± 0.2
Monoterpenes 5.9 ± 0.3
Oxygenated monoterpenes 85.8 ± 0.02
Oxygenated sesquiterpenes 0.64 ± 0.04
Not identified 7.7 ± 0.2
Rosmarinus officinalis L.
NumberCompoundRT (min)LRI aLRI bRelative % c
1Santolina triene7.959159080.1 ± 0.01
2α-Pinene8.6993093224.1 ± 0.2
3Camphene9.269439463.95 ± 0.01
4Dehydrosabinene9.49469560.17 ± 0.01
5β-Pinene10.429689740.32 ± 0.01
6β-Myrcene11.49899918.1 ± 0.3
7o-Cymene12.83101910221.28 ± 0.01
8ρ-Cymene12.99102210230.6 ± 0.001
9Eucalyptol13.391030103134 ± 1
10γ-Terpinene14.46105210600.49 ± 0.01
11Terpinolene15.7107810880.21 ± 0.01
12Camphor18.75114111425.9 ± 0.05
13α-Terpineol21.41119511892.15 ± 0.01
14Verbenone21.81120412049.4 ± 0.1
15Bornyl acetate25.14127712841.23 ± 0.01
16Methyleugenol30.37139614020.22 ± 0.01
Total identified (%) 91.9 ± 0.1
Monoterpenes 39.2 ± 0.6
Oxygenated monoterpenes 52.7 ± 1.1
Not identified 8.1 ± 0.1
Salvia officinalis L.
NumberCompoundRT (min)LRI aLRI bRelative % c
1α-Pinene8.4759269323.3 ± 0.1
2Camphene9.1759419464.4 ± 0.5
3β-Pinene10.3839679740.79 ± 0.02
4β-Myrcene11.1889849910.53 ± 0.04
5Eucalyptol13.2531027103117 ± 2
6Thujone17.1031107110324 ± 1
7β-Thujone17.804112111144.8 ± 0.3
8Camphor18.9941146114229 ± 1
9Isoborneol20.079116811575.0 ± 0.4
10α-Terpineol21.129119011890.46 ± 0.04
11Bornyl acetate25.102127612840.8 ± 0.1
12β-Caryophyllene30.72140414190.466 ± 0.002
13Humulene32.225144114540.69 ± 0.03
Total identified (%) 91.24 ± 0.05
Monoterpenes 9.02 ± 0.66
Oxygenated monoterpenes 81 ± 5
Sesquiterpenes 1.16 ± 0.03
Not identified 8.76 ± 0.14
Thymus vulgaris L.
NumberCompoundRT (min)LRI aLRI bRelative % c
1α-Pinene8.4759269320.012 ± 0.001
2Camphene9.149409460.005 ± 0.0002
3β-Pinene11.249859740.17 ± 0.01
4o-Cymene13.131026102225.324 ± 0.04
5ρ-Cymene13.2181028102314 ± 1
6Limonene13.28102910240.18 ± 0.01
7Eucalyptol13.341103010310.648 ± 0.03
8γ-Terpinene14.461105210540.278 ± 0.002
9Camphor18.591113811410.26 ± 0.004
10Thymol methyl ether22.739122312,1320.609 ± 0.01
11Methyl carvacrol23.142123112410.54 ± 0.01
12Thymol26.311296128941 ± 1
13Carvacrol26.52130012985.1 ± 0.2
14γ-Muurolene34.676149614780.1 ± 0.01
15Caryophyllene oxide37.371155815821.4 ± 0.1
16δ-Cadinol39.769161316380.213 ± 0.01
Total identified (%) 90.3 ± 0.4
Monoterpenes 39.7 ± 1.1
Oxygenated monoterpenes 47.74 ± 0.52
Sesquiterpenes 0.10 ± 0.01
Oxygenated sesquiterpenes 1.61 ± 0.11
Others (%) 1.15 ± 0.02
Not identified 9.7 ± 0.4
a LRI, linear retention index determined on a DB-5MS fused-silica column relative to a series of n-alkanes (C8–C40). b Linear retention index reported in the literature (Adams, 2017). c Relative % is given as the mean ± SD (n = 3).
Table 2. Antioxidant activity (reducing power and DPPH assays) of Lamiaceae essential oils (EC50 (mg/mL)).
Table 2. Antioxidant activity (reducing power and DPPH assays) of Lamiaceae essential oils (EC50 (mg/mL)).
Antioxidant Activity
RPDPPH
O. vulgare1.69 ± 0.07 c9.2 ± 0.6 d
R. officinalis2.79 ± 0.02 b55.9 ± 0.5 a
S. officinalis6.50 ± 0.23 a39.92 ± 1.21 b
T. vulgaris1.63 ± 0.04 c10.68 ± 0.31 c
E2230.053 ± 0.0020.043 ± 0.004
E3020.020 ± 0.0030.009 ± 0.001
BHT0.045 ± 0.0010.071 ± 0.004
BHT, butylated hydroxytoluene; E302, calcium ascorbate; and E223, sodium metabisulphite. In each column, different letters (a, b, c and d) mean significant differences (p < 0.05) between extracts.
Table 3. Cytotoxicity activity of Lamiaceae essential oils (GI50 (µg/mL)).
Table 3. Cytotoxicity activity of Lamiaceae essential oils (GI50 (µg/mL)).
Tumoral Cell Lines
(GI50 Values; µg/mL)
Non-Tumoral Culture
(GI50 Values; µg/mL)
AGSCaCo-2MCF7NCI-H460VERO
O. vulgare48 ± 4 c45 ± 4 c45 ± 4 d84 ± 3 c>400 a
R. officinalis60 ± 3 c221 ± 11 a202 ± 14 b306 ± 11 a>400 a
S. officinalis236 ± 14 a147 ± 16 b249 ± 21 a305 ± 19 a243 ± 21 b
T. vulgaris175 ± 11 b156 ± 10 b159 ± 13 c243 ± 16 b243 ± 11 b
Ellipticine (µM)0.9 ± 0.10.8 ± 0.11.020 ± 0.0041.01 ± 0.010.6 ± 0.1
AGS, human gastric epithelial cell line; CaCo2, human colorectal adenocarcinoma cell line; MCF7, human breast carcinoma cell line; NCI-H460, human lung carcinoma cell line; and VERO, African green monkey kidney cell line. In each column, different letters (a, b, c and d) mean significant differences (p < 0.05) between extracts.
Table 4. Anti-inflammatory activity of Lamiaceae essential oils (GI50 (µg/mL)).
Table 4. Anti-inflammatory activity of Lamiaceae essential oils (GI50 (µg/mL)).
Anti-Inflammatory
(GI50 Values; µg/mL)
RAW264.7
O. vulgare13.3 ± 0.5 b
R. officinalis58.1 ± 1 a
S. officinalis9.5 ± 0.1 c
T. vulgaris8 ± 1 d
Dexametasone (µM)16 ± 1
In each column, different letters (a, b, c and d) mean significant differences (p < 0.05) between extracts.
Table 5. Antibacterial and antifungal activities of Lamiaceae essential oils (% (v/v)).
Table 5. Antibacterial and antifungal activities of Lamiaceae essential oils (% (v/v)).
Antibacterial Activity
O. vulgareT. vulgarisS. officinalisR. officinalisPositive Control
Streptomycin 1 mg/mLMethicillin
1 mg/mL
Ampicillin 10 mg/mL
MICMBCMICMBCMICMBCMICMBCMICMBCMICMBCMICMBC
Gram-negative bacteria
Escherichia coli0.10.080.30.312.52.52.52.50.010.01n.t.n.t.0.20.15
Pseudomonas aeruginosa2.52.5>2.52.5>2.52.5>2.52.50.060.06n.t.n.t.0.60.63
Salmonella enterica0.20.160.61.252.52.52.52.50.010.01n.t.n.t.0.20.15
Yersinia enterocolitica0.20.30.30.62.52.52.52.50.010.01n.t.n.t.0.20.15
Gram-positive bacteria
Bacillus cereus0.22.50.62.52.52.52.52.50.010.01n.t.n.t.n.t.n.t.
Listeria monocytogenes0.12.50.62.51.252.52.52.50.010.01n.t.n.t.0.20.15
Staphylococcus aureus0.30.631.32.52.52.52.52.50.010.010.010.010.20.15
Antifungal Activity
Ketaconazole 1 mg/mL
MICMFCMICMFCMICMFCMICMFC MICMFC
Aspergillus brasiliensis0.10.310.30.310.310.630.310.63 0.060.13
Aspergillus fumigatus0.10.310.10.310.080.310.080.31 0.51
Essential oils were tested in the concentration range of 2.5% to 0.039% (v/v). MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration; MFC, minimum fungicidal concentration. n.t.—non tested.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Spréa, R.M.; Caleja, C.; Finimundy, T.C.; Calhelha, R.C.; Pires, T.C.S.P.; Amaral, J.S.; Prieto, M.A.; Ferreira, I.C.F.R.; Pereira, E.; Barros, L. Chemical and Bioactive Evaluation of Essential Oils from Edible and Aromatic Mediterranean Lamiaceae Plants. Molecules 2024, 29, 2827. https://doi.org/10.3390/molecules29122827

AMA Style

Spréa RM, Caleja C, Finimundy TC, Calhelha RC, Pires TCSP, Amaral JS, Prieto MA, Ferreira ICFR, Pereira E, Barros L. Chemical and Bioactive Evaluation of Essential Oils from Edible and Aromatic Mediterranean Lamiaceae Plants. Molecules. 2024; 29(12):2827. https://doi.org/10.3390/molecules29122827

Chicago/Turabian Style

Spréa, Rafael M., Cristina Caleja, Tiane C. Finimundy, Ricardo C. Calhelha, Tânia C. S. P. Pires, Joana S. Amaral, Miguel A. Prieto, Isabel C. F. R. Ferreira, Eliana Pereira, and Lillian Barros. 2024. "Chemical and Bioactive Evaluation of Essential Oils from Edible and Aromatic Mediterranean Lamiaceae Plants" Molecules 29, no. 12: 2827. https://doi.org/10.3390/molecules29122827

Article Metrics

Back to TopTop